Home › Leading Hematology Journal Publishes Pivotal ELOCTATE Data that...
 

Keywords :   


Leading Hematology Journal Publishes Pivotal ELOCTATE Data that...

2013-11-14 00:31:08| Appliances - Topix.net

WESTON, Mass. & STOCKHOLM-- -- Today Biogen Idec and Swedish Orphan Biovitrum AB announced that the detailed phase 3 data for the companies' investigational long-lasting recombinant factor VIII Fc fusion protein candidate ELOCTATEa were published online in Blood , the journal of the American Society of Hematology .

Tags: data journal leading publishes

Category:Consumer Goods and Services

Latest from this category

All news
06.10'Rightmove is my porn' - the addiction to online property search
05.10A 'painful' Autumn statement and a 'bright' Irish budget
05.10A 'painful' Autumn statement and a 'bright' Irish budget
04.10Should you tip even if the service wasn't worth it?
04.10Ex-Harrods exec: I lost my job due to Al Fayed
04.10How worried should I be about rising oil prices?
04.10EU hits China with big taxes in electric car sales battle
04.10Builders' 2.5bn merger backed after monopoly probe
Consumer Goods and Services »
06.10Hurricane Leslie Graphics
06.10Hurricane Kirk Graphics
06.10Hurricane Leslie Forecast Discussion Number 15
06.10Hurricane Leslie Wind Speed Probabilities Number 15
06.10Hurricane Leslie Public Advisory Number 15
06.10Summary for Hurricane Leslie (AT3/AL132024)
06.10Hurricane Leslie Forecast Advisory Number 15
06.10Hurricane Kirk Forecast Discussion Number 27
More »